19th Jan 2007 11:03
Synergy Healthcare PLC19 January 2007 SYNERGY HEALTHCARE PLC 19 JANUARY 2007 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO ORFROM THE UNITED STATES, CANADA, AUSTRALIA, SOUTH AFRICA OR JAPAN INCREASED RECOMMENDED OFFER BY BREWIN DOLPHIN SECURITIES LTD ("BREWIN DOLPHIN")ON BEHALF OF SYNERGY HEALTHCARE PLC ("SYNERGY" or "THE COMPANY") FOR ISOTRON PLC("ISOTRON") COMPULSORY ACQUISITION AND DE-LISTING OF ISOTRON SHARES Synergy Healthcare announces that further to the announcements made on 2 Januaryand 8 January 2007 and as set out in the Increased Recommended Offer Documentdated 12 December 2006, it has now acquired or has valid acceptances of theIncreased Recommended Offer for over 90 per cent of the Isotron Shares to whichthe offer relates and is exercising its rights to compulsorily acquire theremaining Isotron Shares by applying Schedule 2 of the Takeovers Directive.Synergy yesterday posted compulsory acquisition notices to those IsotronShareholders who have not yet accepted the Increased Recommended Offer. The notices also refer to the cancellation of the listing of Isotron Shares asannounced today by Isotron plc and which is anticipated to take effect on 2March 2007. From that date trading of Isotron Shares on the London StockExchange will cease. The Increased Recommended Offer, including the Cash Alternative, will remainopen for acceptance until 1.00 pm on 1 March 2007. Terms defined in the Increased Recommended Offer Document have the same meaningin this announcement. Enquiries: Synergy Healthcare plc 01332 387 100Richard Steeves, Chief ExecutiveIvan Jacques, Group Finance Director Brewin Dolphin Securities Ltd 0845 270 8600(financial adviser and broker to Synergy Healthcare plc)Mark BradyMatt DavisAndrew Emmott Financial Dynamics 0207 269 7156(PR adviser to Synergy Healthcare plc)David Yates Isotron plc 01793 891 891John Barker, Chief ExecutivePaul Wynne, Finance Director JPMorgan Cazenove Ltd 020 7588 2828(financial adviser and broker to Isotron plc)Mark BreuerMichael Wentworth-StanleyJames MitfordAndrew Truscott Hudson Sandler 020 7796 4133(PR adviser to Isotron plc)Alistair Mackinnon-MussonNicola Savage This announcement does not constitute or form part of, an offer or invitation topurchase or subscribe for any securities. The Offer is made solely by means ofthe Increased Recommended Offer Document and the Form of Acceptance accompanyingthe Increased Recommended Offer Document, which contain the full terms andconditions of the Offer including details of how it may be accepted. Brewin Dolphin is acting for Synergy Healthcare and for no-one else inconnection with the Offer and the Increased Recommended Offer and will notregard any other person as its client nor be responsible to anyone other thanSynergy Healthcare for providing the protections afforded to clients of BrewinDolphin nor for providing advice in relation to the Offer and the IncreasedRecommended Offer or any matter referred to in this announcement. Brewin Dolphinis authorised and regulated by the Financial Services Authority. JPMorgan Cazenove, which is authorised and regulated in the United Kingdom bythe Financial Services Authority, is acting exclusively for Isotron and no oneelse in connection with the Increased Recommended Offer and will not beresponsible to anyone other than Isotron for providing the protections offeredto clients of JPMorgan Cazenove or for providing advice in relation to mattersreferred to in this announcement. The availability of the Offer and the Increased Recommended Offer to IsotronShareholders who are not resident in the United Kingdom may be affected by thelaws of the relevant jurisdictions in which they are located. Persons who arenot resident in the United Kingdom should inform themselves about, and observe,applicable legal or regulatory requirements of their jurisdiction. The Offer and the Increased Recommended Offer will not be made, directly orindirectly, in or into, or by use of the mails, or by any means orinstrumentality (including, without limitation, telex, facsimile transmission,telephone, internet or other forms of electronic communication) of interstate orforeign commerce of, or by any facilities of a national securities exchange of,the United States, Canada, Australia, South Africa or Japan or any otherjurisdiction if to do so would constitute a violation of the relevant laws ofsuch jurisdiction and the Offer and the Increased Recommended Offer cannot beaccepted by any such use, means or instrumentality or otherwise from or withinthe United States, Canada, Australia, South Africa or Japan or any otherjurisdiction if to do so would constitute a violation of the relevant laws ofsuch jurisdiction. Accordingly, copies of this announcement are not being, andmust not be, mailed or otherwise forwarded, distributed or sent in or into orfrom any such jurisdiction. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SYR.L